Kusajili – Clinical trials directory

Your research

Source: nct - Country: Japan,Denmark,Netherlands,Belgium,Poland,Germany,Russian Federation,Romania - Promoter: Vicente Torres, MD, PhD

Vicente Torres, MD, PhD Update Il y a 5 ans

Tolvaptan Phase 3 Efficacy and Safety Study in ADPKD This study's purpose is to evaluate the long-term safety and efficacy of tolvaptan versus placebo in patients with ADPKD.

Country Argentina, Australia, Belgium, Canada, Denmark, France, Germany, Italy, Japan, Netherlands, Poland, Romania, Russian Federation, United Kingdom, United States,
organs None
Specialty None

Closed trial

More information

1